Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Shifa International Hospital | OTHER |
| Chongqing Medical University | OTHER |
Not provided
Not provided
Not provided
Not provided
The intracerebral hemorrhage study is a multicenter , combination of prospective and retrospective observational cohort study led by Dr. Muhammad Junaid Akram, PhD scholar at Chongqing Medical University. Prof Dr. Qi Li will be the senior consultant for the study. The study will be focusing on natural history, epidemiological , radiological, rehabilitative and clinical aspects as well as the effect of various treatments on the hemorrhagic patients.
The study related data of the patients diagnosed with intracerebral hemorrhage will be collected in prospective and retrospective ways. The prognostic data for the patients will be assembled and collected via using different outcome measures at different points of time.
The study will be used to address the several key issues related to intracerebral hemorrhage. The demographics, scores based upon disease severity , mRS, GCS, NIHSS scores will be recorded at baseline and in the prospective and retrospective ways. The data obtained from the registered patients will be used for future use , critical review by expert neurologists, neurorehabilitative experts for further use and review.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Benign Hematoma | Patients (having novel image markers or clinical features) suggestive of a benign hematoma relatively , that is having relatively good prognostic outcome and less likely to expand. | ||
| Malignant Hematoma | Patients (having novel image markers or clinical features) suggestive of a malignant hematoma relatively, that is more likely to expand and have poor prognostic outcome. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| hematoma volume growth at 24 hours | To assess early hematoma volume growth at 24 hours | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Functional outcome at 3 months assessed by modified Rankin Scale | Assess functional outcome at 3 months by using mRS | 3 months |
| Early neurological deterioration assessed by NIHSS score at 24 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population will be comprising of the participants willing to participate in the study with an age greater than 18 years from Pakistan.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Muhammad Junaid Akram, DPT, MS-NMPT | Contact | 0092-335-1402214 | drjunaidmalik2@gmail.com | |
| Muhammad Junaid Akram | Contact | 0092-335-1402214 | drjunaidmalik2@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Muhammad Junaid Akram, DPT, MS-NMPT | Chongqing Medical University, Chongqing / Shifa Tameer e Millat University, Islamabad | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shifa Tameer e Millat University | Recruiting | Islamabad | 46000 | Pakistan |
Undecided yet
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002543 | Cerebral Hemorrhage |
| D020521 | Stroke |
| D006406 | Hematoma |
| ID | Term |
|---|---|
| D020300 | Intracranial Hemorrhages |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
To assess early neurological deterioration by using NIHSS score at 24 hours
| 24 hours |
| Early neurological deterioration assessed by NIHSS score at 48 hours | To assess early neurological deterioration by using NIHSS score at 48 hours | 48 hours |
| Early neurological deterioration assessed by NIHSS score at 72 hours | To assess early neurological deterioration by using NIHSS score at 72 hours | 72 hours |
| Perihematomal edema volume measurement at 24 hours | To measure the perihematomal edema volume growth at 24 hours | 24 hours |
| Perihematomal edema volume measurement at 48 hours | To measure the perihematomal edema volume growth at 48 hours | 48 hours |
| Perihematomal edema volume measurement at 72 hours | To measure the perihematomal edema volume growth at 72 hours | 72 hours |
| Intraventricular hemorrhage growth | To assess the presence of IVH at 24 hours | 24 hours |
| Major thrombotic events | To assess the thrombotic events 2 weeks after admission | 2 weeks |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |